Author: Jens Kurth

Restoring a classic car teaches you a lot about patience, systems, and respect for history.

When I spend evenings on my Mercedes R107, I’m reminded how similar the process is to managing change in organizations:

🚗 You diagnose before acting — is the issue really the fuel injection system, or something deeper in the wiring? Just like in companies, the visible symptom often isn’t the root cause.

🚗 You take a system view — fixing brakes without aligning the suspension creates imbalance. In organizations, introducing new tools without aligning people and processes does the same.

🚗 You honor the past while modernizing for the future — an old Mercedes keeps its character even when updated. Companies too must respect their culture while evolving.

🚗 You move step by step — bodywork, electrics, engine, interior. Change also works in phases: awareness, desire, knowledge, ability, reinforcement.

In both cases, success isn’t about rushing. It’s about precision, patience, and having the right tools and frameworks.

That’s the mindset I bring to change management at Crowlight Partners: combining structure with respect, and making sure that after the “repair,” the system runs reliably and sustainably.

I’d like to hear from others: what hobbies have taught you lessons that carry over into your professional life?

The future of healthcare is not just new therapies — it is new ways of empowering patients.

At the intersection of biomedicine and digital technology, we now have the tools to move from reactive to proactive care:

• AI-driven biomarkers and digital twins predict disease before it manifests
• Remote monitoring supports patients in managing chronic conditions between visits
• Digital platforms make it possible for patients to understand their own data and participate in shared decision-making

Regulators are taking notice.

EMA and FDA are already encouraging the use of digital biomarkers, decentralized trials, and patient-reported outcomes to strengthen evidence generation. Patient empowerment is no longer just a vision — it is finding its way into regulatory frameworks that guide approvals, reimbursement, and market access. The key challenge: maintaining trust, data quality, and privacy while enabling innovation.

This shift could create extraordinary value — earlier interventions, more precise treatments, and ultimately, patients who feel not only cared for, but in control.

Where do you see the greatest potential for digital technologies to truly empower patients?